Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Claris IPO.
April 11, 2024 12:30:00 PM
With Instacart, Arm, and Klaviyo going public, the IPO market could be reviving this year. BI profiled 11 startups that are expected to IPO, according to PitchBook's Exit Predictor. It's been a ...
Published by : Business InsiderApril 18, 2024 9:56:00 AM
IPO stocks as good as CrowdStrike are few and far between, but one can quickly explain why it's worked out well in this case. There's good evidence that CrowdStrike is a top player in the ...
Published by : The Motley FoolApril 22, 2024 7:57:00 PM
The IPO market is heating up after a long lull. Instacart, Birkenstock, and Arm are among recent debuts.. IPO stocks are significantly riskier than the broad market. After a boom in IPOs during ...
Published by : The Motley FoolApril 19, 2024 11:45:00 PM
The initial public offering (IPO) market is in rally mode in April, as interest rates moderate and stock valuations bounce back for publicly traded companies. Last year, significant growth ...
Published by : U.S. News & World ReportMay 6, 2024 3:30:00 AM
The Rs 1,841.76 crore IPO of Indegene includes a fresh share sale of Rs 760 crore and an offer-for-sale of up to 2,39,32,732 equity shares by its promoters and existing equity shareholders.
Published by : Business TodayApril 18, 2024 8:32:00 PM
Centuri's IPO of 12.4M shares was priced at $21.00 per share on Wednesday. In addition, Centuri (CTRI) has granted the underwriters a 30-day option to purchase up to an additional 1.86M shares.
Published by : Seeking AlphaMay 6, 2024 10:10:00 PM
Indegene Ltd IPO, which opened for subscription today, has already got positive response. The Rs 1,842-crore IPO is a mix of fresh issue and offer for sale by existing shareholders. The price band ...
Published by : moneycontrol.comApril 8, 2024 12:24:00 PM
Casual-dining restaurant chain Panera Bread is well-positioned for a potential IPO amid growing foot traffic to its locations, according to data from analytics company Placer.ai. Last year the ...
Published by : MarketWatchApril 19, 2024 1:37:00 PM
Cheddar TV�s Kristen Scholer interviewed IPO Edge Editor-in-Chief John Jannarone to discuss how technology and cloud-based services companies are driving an IPO revival, with firms like Ibotta ...
Published by : Yahoo FinanceIPO Listing Detail
Listing Date: Monday, December 20, 2010
BSE Scrip Code: 533288
Listing In: 'B' Group of Securities
ISIN: INE562G01018
Issue Price: Rs. 228.00 Per Equity Share
Face Value: Rs. 10.00 Per Equity Share
Claris Lifesciences Ltd IPO allotment status is now available online.
Claris Lifesciences IPO was open on Nov 24, 2010 and closed on Dec 02, 2010. IPO of Claris was oversubscribed by 1.50 times (1.60 times in retail).
Claris Lifesciences Ltd (CLL) IPO finally subscribed 1.50 times on its closing day. Claris IPO was open on Nov 24, 2010 and closed today on Dec 02, 2010 for subscription.
Oversubscription detail
Qualified Institutional Buyers (QIBs): 1.31 Times
Non Institutional Investors: 2.03 Times
Retail Individual Investors (RIIs): 1.60 Times
Total: 1.50 Times
Alert:
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share
Claris Lifesciences Limited (CLL) is entering in the capital markets with an initial public offering, IPO of Rs. 300.00 Crore. The price band for the issue has been fixed at Rs 278/- at lower level and Rs 293/- at upper level.
Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
The issue opens on Nov 24, 2010, and closes for subscription on Nov 26, 2010. The equity shares of the issue are proposed to be listed on the Bombay Stock Exchange (BSE).
The Claris IPO is proposed to open on November 24, 2010. The IPO application ends on December 2, 2010.
Retail investors can apply in the retail or non-institutional investor category from November 24, 2010 to December 2, 2010. The Claris IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Claris IPO will open for subscription on November 24, 2010. The public issue will close on December 2, 2010.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
